DELRAY BEACH, Fla., Aug. 22, 2025 /PRNewswire/ -- The global Empty Capsules Market, valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$4.19 billion by the end of the period. The empty capsules market is propelled by increasing demand for nutraceuticals and personalized supplements, expansion in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options, combined with sustainability-driven regulations, is further accelerating adoption. Future growth is anticipated from localized production in emerging markets and the creation of biodegradable capsules.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190
Browse in-depth TOC on "Empty Capsules Market"
356 - Tables
48 - Figures
459 - Pages
By functionality, the empty capsules market is categorized into immediate-release capsules, sustained-release capsules, delayed-release capsules, and modified-release capsules. The immediate-release capsules segment is the largest in the empty capsules market. These capsules are typically used for medications and supplements where a rapid onset of action is necessary. They are the most commonly used type of capsule, favored for their simple formulation and relatively low production cost. Immediate-release capsules are employed in treating acute conditions such as pain relief, antibiotics, and other fast-acting drugs.
By application, the empty capsules market is categorized based on therapeutic applications, including antibiotic and antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold treatments, and other therapeutic uses. Among these, the dietary supplements segment is the fastest growing, driven by the increasing demand for natural supplements, probiotics, and vegan alternatives. This growth is fueled by a shift toward preventive healthcare and a rising interest in personalized nutrition. Additionally, the development of plant-based and clean-label products contributes to this segment's expansion as consumers become more health-conscious and choose supplements that match their dietary preferences. The global aging population and the rising prevalence of lifestyle diseases also boost the reliance on dietary supplements as part of proactive health management.
By geography, the empty capsules market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America held the largest share of the global empty capsules market, driven by its well-established pharmaceutical and nutraceutical industries, high healthcare expenditure, and increasing demand for dietary supplements. Furthermore, the rising preference for vegetarian and clean-label capsules among health-conscious consumers has further fueled demand. Regulatory support and a high volume of clinical trials also help maintain the region's leading position in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190
Key players in the empty capsules market include Lonza (Switzerland), ACG (India), Qualicaps (US), Suheung (South Korea), and Shanxi Guangsheng Capsule Limited (China), among others. Some of the SMEs/start-ups operating in this market includes Saviour Caps (India), Shanxi JC Biological Technology Co. (China), Shaoxing Kangke Capsule Co., Ltd. (China), ZHEJIANG HUILI CAPSULES CO., LTD. (China), and Lefancaps (Canada), among others.
Lonza (Switzerland):
Lonza (Switzerland), through its Capsules & Health Ingredients (CHI) segment (formerly Capsugel), offers a broad portfolio of gelatin and non-gelatin capsules, including well-known brands like Vcaps, Vcaps Plus, DRcaps, and Enprotect, serving both pharmaceutical and nutraceutical industries. With a production capacity of approximately 260 billion capsules and over 12 manufacturing sites, Lonza operates globally, supporting more than 5,000 customers. In 2024, Lonza's CHI segment generated USD 1.27 billion in revenue, despite weakening demand in consumer health. Lonza highlighted capsule innovation by expanding its targeted release technologies and plant-based portfolio in line with clean-label trends. The company launched Capsugel Enprotect in 2022, the first coating-free capsule for enteric drug delivery, targeting small molecules, peptides, proteins, and RNA-based therapeutics. Lonza maintained its market position through a broad portfolio, trusted quality, global presence, strong customer relationships, technological leadership, and operational efficiency. In December 2024, Lonza announced the separation of its CHI business and plans to operate solely as a CDMO. The separation is expected to take effect in Q2 2025.
ACG (India)
ACG (India) is the second-largest global player and the leading capsule manufacturer from India, with a strong international presence in gelatin and HPMC capsules manufacturing. ACG Capsules (ACPL) is projected to generate USD 400 million in 2024. The company is focused on expanding globally, especially through new facilities in Thailand and upgrades to its Croatia plant. ACG also offers customized capsule solutions, including halal and kosher-certified gelatin, catering to Middle Eastern and Southeast Asian markets. Its strengths include cost competitiveness, regulatory flexibility, and a vertically integrated supply chain, positioning ACG as a dependable partner for both pharma and nutraceutical sectors and CDMOs.
For more information, Inquire Now!
Related Reports:
Pharmaceutical Packaging Equipment Market
Active Pharmaceutical Ingredient Market
Pharmaceutical Contract Manufacturing Market
Drug Discovery Services Market
Pharmaceutical Excipients Market
Get access to the latest updates on Empty Capsules Companies and Empty Capsules Market Size
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/empty-capsules-market-worth-4-19-billion-by-2030-with-5-6-cagr--marketsandmarkets-302536501.html
